Gauruv Bose
Overview
Explore the profile of Gauruv Bose including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
183
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Thebault S, Fereshtehnejad S, Bergman H, Breville G, Abdoli M, Booth R, et al.
Sci Rep
. 2024 Nov;
14(1):29135.
PMID: 39587121
Our objective was to evaluate the individual and combined prognostic attributes of baseline serum and CSF measurements of Neurofilament light chain (sNfL, cNfL) and glial fibrillary acidic protein (sGFAP, cGFAP)...
2.
Cross A, Gelfand J, Thebault S, Bennett J, von Budingen H, Cameron B, et al.
JAMA Neurol
. 2024 Mar;
PMID: 38466277
Importance: Biomarkers distinguishing nonrelapsing progressive disease biology from relapsing biology in multiple sclerosis (MS) are lacking. Cerebrospinal fluid (CSF) is an accessible fluid that most closely reflects central nervous system...
3.
Molazadeh N, Bilodeau P, Salky R, Bose G, Lotan I, Romanow G, et al.
J Neurol Sci
. 2024 Feb;
458:122909.
PMID: 38335710
Background: Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is an autoimmune disease that can present as a monophasic or relapsing disease course. Here, we investigate the predictors of developing relapsing disease...
4.
Molazadeh N, Akaishi T, Bose G, Nishiyama S, Chitnis T, Levy M
Mult Scler Relat Disord
. 2023 Nov;
80:105093.
PMID: 37949025
Objectives: To determine whether progression independent of relapse activity (PIRA) is present in Aquaporin4-IgG-seropositive neuromyelitis optica spectrum disorder (AQP4+NMOSD), Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) and relapsing remitting Multiple sclerosis...
5.
Bose G, Healy B, Saxena S, Saleh F, Glanz B, Bakshi R, et al.
Neurol Neuroimmunol Neuroinflamm
. 2023 Oct;
10(6).
PMID: 37813595
Background And Objectives: Stable patients with multiple sclerosis (MS) may discontinue treatment, but the risk of disease activity is unknown. Serum neurofilament light chain (sNfL) and serum glial fibrillary acidic...
6.
Bose G, Healy B, Barro C, Moreira Ferreira V, Saxena S, Glanz B, et al.
Mult Scler
. 2023 Sep;
29(11-12):1418-1427.
PMID: 37712409
Background: Contrast-enhancing magnetic resonance imaging (MRI) lesions (CELs) indicate acute multiple sclerosis inflammation. Serum biomarkers, neurofilament light (sNfL), and glial fibrillary acidic protein (sGFAP) may increase in the presence of...
7.
Gonzalez-Martinez A, Bose G, Lokhande H, Saxena S, Healy B, Polgar-Turcsanyi M, et al.
J Neuroinflammation
. 2023 Jun;
20(1):136.
PMID: 37264432
Background: Multiple sclerosis (MS) is a chronic demyelinating autoimmune disorder which may cause long-term disability. MicroRNA (miRNA) are stable, non-coding molecules that have been identified in our Comprehensive Longitudinal Investigation...
8.
Bose G, Healy B, Saxena S, Saleh F, Paul A, Barro C, et al.
Mult Scler Relat Disord
. 2023 Apr;
74:104695.
PMID: 37060852
Background: Early risk-stratification in multiple sclerosis (MS) may impact treatment decisions. Current predictive models have identified that clinical and imaging characteristics of aggressive disease are associated with worse long-term outcomes....
9.
Conway S, Saxena S, Baecher-Allan C, Krishnan R, Houtchens M, Glanz B, et al.
Mult Scler J Exp Transl Clin
. 2023 Apr;
9(2):20552173231165196.
PMID: 37057191
Background: There is limited knowledge about T cell responses in patients with multiple sclerosis (MS) after 3 doses of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mRNA vaccine. Objectives: Assess...
10.
Molazadeh N, Bose G, Lotan I, Levy M
Mult Scler J Exp Transl Clin
. 2022 Oct;
8(4):20552173221128170.
PMID: 36311694
Background: Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) has various similarities with AQP4-IgG-seropositive Neuromyelitis Optica Spectrum Disorder (AQP4-IgG + NMOSD) in terms of clinical presentations, magnetic resonance imaging (MRI) findings, and...